Business
Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016
Covalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab H...
About this update from Covalon Technologies Ltd.
[{"type":"text","content":"\n\n\n\nCovalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCovalon Presenting Its Latest Advanced Wound Care and Infection Control Products at Arab Health 2016\nCanada NewsWire\nMISSISSAUGA, ON, Jan. 21, 2016\n\n\n\nMISSISSAUGA, ON, Jan. 21, 2016 /CNW/ - Covalon Technologies Ltd. (the \"Company\" or \"Covalon\") (TSXV: COV), an advanced medical technologies company, today announced it is presenting its latest line of advanced wound care and healthcare acquired infection control products from January 25th-28th at the Annual Arab Health Congress in Dubai, U.A.E. Arab Health provides an opportunity for Covalon to meet the 65,000 medical and scientific community attendees, medical product manufacturers, wholesalers and distributors from the Middle East, Asia, Europe, North America and most other regions of the world.\n\nCovalon will be showcasing its category transforming products at Arab Health, including SurgiClear™ and IV Clear™ – breathable, clear, dual antimicrobial silicone adhesive surgical wound and vascular access securement dressings, as well as ColActive Plus Ag, a patented BioMatrix wound dressing available for use in most Middle Eastern jurisdictions.\n\n\"With this being our 5th year at the Arab Health Congress, we have shown not only our commitment to launching innovations into the region, but the region has shown us in return its willingness to be leaders in the adoption of new medical technologies that address its biggest healthcare challenges.\" said John Hands, Covalon's Senior Director of Global Marketing. \"After rigorous evaluations by leading physicians and clinicians in Saudi Arabia, Qatar, Kuwait, UAE, Bahrain, Oman and other countries, our products have been successful in winning business in no less than 14 tenders this past year alone.  Covalon and our brands are becoming market leaders in the Middle East as a result of the hard work of our partners in the region, like Cure Development International Ltd.\"\n\n\"We are pleased ...